PubMed Health⌕ Search

Biomedical subjects

G Nudelman

Publications and source records attributed to G Nudelman.

2 recordsLinked to original sources

Cell surface dynamics: the balance between diffusion, aggregation and endocytosis.

The cell membrane lies at the interface between an extracellular set of signals and the appropriate intracellular response. Specifically, lymphocyte activity is determined by the spatial and structural response to antigens, as mediated by cell surface receptors. In order to correlate experimentally observed cellular activities, such as secretion, anergy, death, survival and division to external stimuli, it is necessary to monitor cell surface dynamics. B-lymphocyte activation results from the stimulation by large immune complexes comprising antigens, B-cell receptors (BcRs) and co-receptors. Compartmentalisation of the interacting molecular components is required in order to assure the rapid initiation of specialised and sustained signalling cascades. In this study, a Monte Carlo simulation of the cell membrane dynamics was developed to clarify the receptor dynamics, aggregation mechanisms and their combined effect on cellular functions. This simulation is based on experimentally measured parameters and represents a feasible, advanced and reliable framework to investigate the cell surface. The current study focussed on B-cell surface dynamics. A model demonstrating the basic properties of BcR dynamics and how BcR kinetics is affected by lipid rafts is developed. The authors studied BcR interactions with multivalent ligands and the influence of lipid rafts on this interaction. Finally, the dynamics of the initial steps of BcR-mediated cell activation is estimated and the effect of the association of signalling molecules with lipid rafts is demonstrated. These results are used to suggest some novel hypotheses on BcR-mediated B-cell activation.

Animals↗

2-substituted pi system derivatives of adenosine that are coronary vasodilators acting via the A2A adenosine receptor.

Compound 20 (CVT-3146--a 2-[(N-1-(4-N-methylcarboxamidopyrazolyl)] adenosine derivative) and compound 31 (CVT-3033--a 2-[(4-(1-N-pentylpyrazolyl)] adenosine derivative), were found to be short acting functionally selective coronary vasodilators (CV t0.5 = 5.2 +/- 0.2 and 3.4 +/- 0.5 min, respectively--rat isolated heart 50% reversal time) with good potency (EC50S = 6.4 +/- 1.2 nM and 67.9 +/- 16.7 nM, respectively), but they possess low affinity for the ADO A2A receptor (Ki = 1122 +/- 323 nM and 2138 +/- 952 nM, respectively; pig striatum).

Adenosine↗